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Patients with extensive peritoneal spread from advanced ovarian cancer often undergo several upper abdominal
surgical procedures including subphrenic peritonectomy to obtain optimal cytoreduction. The most common
complications are pleural effusions, pancreatic leakage and endoabdominal collections. This case report describes
an unusual complication, a diaphragmatic hernia with an intrathoracic gastric volvulus developing four months
after the patient underwent left subphrenic peritonectomy during interval debulking surgery and hyperthermic
intraperitoneal chemotherapy for advanced ovarian cancer.
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Peritoneal spread is a typical feature in patients with pri-
mary advanced or recurrent ovarian cancer. Since the first
report by Griffith [1] multiple retrospective series have
shown that survival is inversely proportional to residual
tumor size [2]. After a meta-analysis showed that maximal
cytoreduction improves prognosis [3], the criteria for
defining desirable surgical outcome in advanced ovarian
cancer (AOC) switched from ‘optimal debulking’ with
variable residual disease up to 1 to 2 cm in diameter, to
microscopic residual disease alone. These findings justified
more aggressive surgery including, as in other peritoneal
carcinomatoses, hyperthermic intraperitoneal chemother-
apy (HIPEC) [4,5]. In patients with extensive peritoneal
spread from AOC, bulky upper abdominal disease often
precludes optimal cytoreduction thus lowering survival
rates [6]. To achieve better cytoreduction rates and* Correspondence: roberto.caronna@uniroma1.it
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reproduction in any medium, provided the orimprove outcome, centers highly experienced in treating
AOC, therefore, now recommend extending standard
cytoreduction with extensive upper abdominal surgical
procedures, including subphrenic peritonectomy, sple-
nectomy, distal pancreatectomy or tumor stripping from
Glisson’s capsule [7-9]. Diaphragmatic surgery includes
various procedures, such as subphrenic peritonectomy
originally proposed by Sugarbaker (stripping) [10], coagu-
lating minimal lesions less than 5 mm in diameter or, in
patients with extensive spread infiltrating the muscle and
sometimes the adjacent pleura, full-thickness resection
[8]. Diaphragmatic surgery carries its own specific morbid-
ity, mainly including pleural and pulmonary complications
(pleural effusions, pneumothorax, pulmonary infections
and the need for intrathoracic drainage). Less frequently,
it also leads to morbidity related to the other upper ab-
dominal surgical procedures frequently associated with
subphrenic peritonectomy, such as splenectomy or distal
pancreatectomy leading to pancreatitis, digestive fistulas
or abdominal collections [9,11,12]. This case report de-
scribing a patient in whom a delayed diaphragmatic hernial Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Preoperative plain abdominal X ray showing left
hemidiaphragm lifting and gastric overdistension.
Figure 2 Preoperative plain computed tomographic scan
showing left hemidiaphragm lifting and gastric overdistension.
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nic peritonectomy for AOC underlines the need to take
this possible late complication related to these multiple
upper abdominal surgical procedures into account during
postoperative follow-up.
Case presentation
A 51-year-old woman was diagnosed with a clinical stage
IIIC International Federation of Gynecology and Obstetrics
(FIGO) serous ovarian carcinoma in October 2011. Diag-
nostic laparoscopy showed that debulking surgery as a
front-line approach was unlikely to leave no residual tumor
so the patient received three courses of paclitaxel and
carboplatin neoadjuvant chemotherapy to which she par-
tially responded. When she was hospitalized in January
2012 for interval debulking surgery, intraoperative
evaluation showed peritoneal carcinomatosis involving
the pelvis, the omentum and the undersurface of both
diaphragmatic domes leading to a peritoneal cancer
index according to Sugarbaker of 21 [13]. The patient
underwent pelvic peritonectomy with bilateral hysteroad-
nexectomy, appendectomy, cholecystectomy, infragastric
omentectomy, bilateral subphrenic peritonectomy and
pelvic and lumboaortic lymphadenectomy yielding a com-
pleteness of cytoreduction (CC) score of 0 [14]. When the
surgical procedure ended, HIPEC was given with a cis-
platin solution (75 mg/m2) at 43°C for 60 minutes using
the closed abdomen technique. Pathological staging classi-
fied the tumor as ypT3b pN0 pM0 G3 FIGO stage IIIB.
The postoperative course was uneventful and the patient
was discharged 11 days after surgery. The patient received
consolidation adjuvant chemotherapy with paclitaxel and
carboplatin over the next three months and one month
later she was readmitted to the hospital with suspected
intestinal occlusion. Radiological studies showed left
hemidiaphragm lifting and gastric overdistension but no
documentable pathological tissue or abdominal fluid col-
lections (Figures 1 and 2). Emergency laparotomy
disclosed a wide breach in the left diaphragm with a gas-
tric volvulus herniating into the chest (Figure 3) but no
signs indicating recurrent disease. We repositioned the
stomach in the abdominal cavity and directly sutured the
diaphragmatic breach (no postoperative pleural drainage
was necessary). Histological examination of frozen sec-
tions from perioperative peritoneal biopsy samples ex-
cluded recurrent disease. The postoperative course was
uneventful. The patient soon recovered completely and
was discharged after a week. She is now under follow-
up and clinically disease-free.
Discussion
A delayed diaphragmatic hernia is an exceptional compli-
cation in a patient with AOC who has undergone exten-
sive upper abdominal surgical procedures for maximalcytoreduction. To our knowledge, the literature describes
only three similar left-sided cases, given that the liver usu-
ally protects the right diaphragm against this event
[15,16]. Two of these three cases differ from the case we
report here because the clinical features strongly suggest
that the diaphragmatic hernia arose for reasons only par-
tially related to diaphragmatic surgery. In the patient de-
scribed by Laterza et al. [15] and in one of the two cases
described by Lampl et al. [16], the colonic fistula that de-
veloped in the splenic flexure after cytoreductive surgery
caused an abdominal abscess that invaded through the
Figure 3 Intraoperative photograph showing the wide breach
in the left diaphragm.
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duction included a left subphrenic peritonectomy only in
the patient described by Laterza et al. [15]. In the patient
we describe here, as in the second patient reported by
Lampl et al. [16], the diaphragmatic hernias both had a
delayed onset after cytoreductive surgery including sub-
phrenic peritonectomy and were both unrelated to other
surgical complications. The only difference concerned the
clinical onset because in our patient the ruptured dia-
phragm caused an intrathoracic gastric volvulus necessi-
tating emergency surgery whereas in the case reported by
Lampl et al. [16], although computed tomographic (CT)
scans obtained during follow-up showed the diaphrag-
matic hernia progressing over time; only when the symp-
toms and dyspepsia increased did the patient undergo
surgery. What events cause a diaphragmatic hernia to
complicate cytoreductive surgery including subphrenic
peritonectomy and HIPEC remains conjectural. The clin-
ical history suggests that in the case we report several
causes probably acted in concert. First, peritoneal malig-
nant implants involving the diaphragm presumably in-
jured the muscle and the resulting trauma then continued
when the patient underwent neoadjuvant chemotherapy
followed by surgery. Necrosis in response to neoadjuvant
chemotherapy, as others have reported after diaphrag-
matic surgical procedures done for interval debulking sur-
gery [12], might play a role in increasing the complication
rate. In our patient, the subphrenic peritonectomy done
during debulking could then have aggravated the previous
diaphragmatic trauma when the high-voltage stripping
knife induced a thermal shock. Last, HIPEC done even for
a short time with the closed abdomen technique caused
endoabdominal pressure to increase, thus further trauma-
tizing the diaphragmatic muscle. In our opinion, no spe-
cific measures can prevent this infrequent complication
after cytoreductive surgery including subphrenic perito-nectomy except, possibly, carefully checking intraopera-
tively that surgery leaves the diaphragm intact. As a patho-
genetic explanation, we suggest that our patient’s delayed
diaphragmatic hernia, like those sometimes developing
after blunt trauma [17], became clinically manifest only
when the diaphragmatic trauma devitalized the muscle
and caused peripheral denervation, thus progressively
thinning the muscle wall and inducing fibrosis until the
diaphragm ruptured and the complication turned into a
clinical urgency.
Conclusions
Our case report serves as a useful reminder that phy-
sicians following patients with AOC who undergo a
subphrenic peritonectomy, especially patients who have
received neoadjuvant chemotherapy, should keep this
possible complication in mind. The only possible way to
prevent this almost unpredictable event is to check that
small accidental diaphragmatic perforations left after
peritoneal stripping are not overlooked and remain
unsutured.
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